Marker Therapeutics Announces Board Resignation

Houston-based biopharmaceutical company Marker Therapeutics, Inc., with a market capitalization of $20.45 million, reported a change in its board composition earlier this week. On Thursday, the firm announced the resignation of Mr. John Wilson from its Board of Directors, effective January 24, 2025. The details surrounding Mr. Wilson's departure have not been disclosed, and the company has not named a successor at this time.

You May Also Be Interested In

• Robo.ai names three executives to lead UAE subsidiary Neurovia AI
• Repay rejects Forager Capital's $5.25-per-share acquisition bid
• Brand Engagement Network and Accelevate launch fleet ad platform